Angiocrine factors, mediating the endothelial-mural cell interaction in vascular wall construction as well as maintenance, are incompletely characterized. Here we show that loss of follistatin-like protein 1 (FSTL1) in endothelial cells (Fstl1 ECKO ) led to an increase of pulmonary vascular resistance, resulting in the heart regurgitation especially with tricuspid valves. However, this abnormality was not detected in mutant mice with Fstl1 deletion in smooth muscle cells or hematopoietic cells. We further showed that there was excessive alpha-smooth muscle actin (αSMA) associated with atrial endocardia, heart valves, veins and microvessels after the endothelial FSTL1 deletion. Consistently, there was an increase of collagen deposition as demonstrated in livers of Fstl1 ECKO mutants. The SMAD3 phosphorylation was significantly enhanced and pSMAD3 staining was colocalized with αSMA in vein walls, suggesting the activation of TGFβ signaling in vascular mural cells of Fstl1 ECKO mice. The findings imply that endothelial FSTL1 is critical for the homeostasis of atria and veins and its insufficiency may favor cardiovascular fibrosis leading to heart failure.
Introduction
Vascular endothelial cells (ECs) provide structural support for blood circulation by lining the inner layer of tubular vessels and also actively participate in the assembly of the vascular network during organogenesis by secreting various angiocrine factors (Rafii, Butler et al. 2016) . For example, endothelial-derived PDGF-B was required for recruiting mural cells expressing PDGFRβ (Leveen, Pekny et al. 1994 , Soriano 1994 ).
Mural cells are essential components of blood vascular walls, including pericytes in microvessels and smooth muscle cells (SMCs) in large blood vessels. They exert important roles in vascular function and homeostasis (Armulik, Genove et al. 2011) .
TGFβ signaling, a crucial pathway for vascular development, is involved in the regulation of mural cell proliferation and differentiation from mesenchymal cells (Gaengel, Genove et al. 2009 ). Knockout of the TGFβ pathway-related genes, including TGFβ1, type I or II receptors, endoglin and the downstream SMADs, leads to the defective vascular formation with abnormal recruitment of mural cells (Li, Sorensen et al. 1999 , Yang, Castilla et al. 1999 , Oh, Seki et al. 2000 , Larsson, Goumans et al. 2001 , Carvalho, Itoh et al. 2007 , Goumans, Liu et al. 2009 , Li, Lan et al. 2011 , Larrivee, Prahst et al. 2012 ). On the other hand, TGFβ1 was also shown to be a key mediator in tissue fibrosis, a pathophysiological response of tissues to an insult by the recruitment of inflammatory cells, the activation of myofibroblasts and the deposition of extracellular matrix in the affected tissues (Wynn and Ramalingam 2012 , Samarakoon, Overstreet et al. 2013 , Harvey, Montezano et al. 2016 , Schafer, Viswanathan et al. 2017 ).
Follistatin-like 1 (FSTL1, also known as TSC36 or FRP) was a secreted glycoprotein first identified as a TGF-β1 inducible factor (Shibanuma, Mashimo et al. 1993) . FSTL1 is expressed by many types of cells including endothelial cells and smooth muscle cells (Adams, Larman et al. 2007 , Shimano, Ouchi et al. 2011 , Miyabe, Ohashi et al. 2014 , and exerts biological functions in various tissues in development and diseases (Sylva, Moorman et al. 2013 ). In the circulatory system, it has been reported that FSTL1 is cardio-protective and epicardial FSTL1 was shown to stimulate the division of pre-existing cardiomyocytes in animal models with myocardial infarction (Lara-Pezzi, Felkin et al. 2008 , Shimano, Ouchi et al. 2011 , Wei, Serpooshan et al. 2015 . FSTL1 has also been shown to promote angiogenesis, endothelial cell survival and function , Liu, Shen et al. 2010 . At the molecular level, FSTL1 was reported to modulate the BMP and TGFβ mediated signaling pathway (Tanaka, Murakami et al. 2010 , Geng, Dong et al. 2011 , Sylva, Li et al. 2011 , Xu, Qi et al. 2012 , Prakash, Borreguero et al. 2017 .
Although both vascular endothelial cells and smooth muscle cells express high levels of FSTL1, little is known about the differential requirement of specific cell-derived FSTL1 in blood vascular formation and maintenance. We found in this study that deletion of Fstl1 in endothelial cells, but not in SMCs or blood cells, led to an increase of atria-as well as vein-associated alpha-smooth muscle actin (αSMA) positive cells in several organs examined. Vascular smooth muscle tissues participate in the 6 regulation of peripheral blood pressure via their contraction and relaxation. The pathological vascular remodeling would increase the vascular resistance as reflected by the occurrence of heart regurgitation, leading ultimately to the heart failure of Fstl1 ECKO mice.
Results

Tricuspid regurgitation of mutant mice with endothelial Fstl1 deletion
As mice null for Fstl1 died at birth (Geng, Dong et al. 2011 , Sylva, Li et al. 2011 , we generated the mice with Fstl1 deletion in endothelial cells using the Tek-Cre (Koni, Joshi et al. 2001) . We found that FSTL1 was highly expressed by endothelial cells (Fig. 1A-C ). Fstl1 deletion in endothelial cells was examined by immunostaining for PECAM-1 and FSTL1 ( Fig.   1A , arrows), Western blot analysis (Fig. 1B) , and quantitative RT-PCR (Fig. 1C ). The relative level of Fstl1 transcripts in mutant lung was reduced to about 35 % of the wildtype control (Fstl1 Flox/+ : 1.0 ± 0.27, n=7; Fstl1 Flox/-, 0.57 ± 0.18, n=6; Fstl1 ECKO : 0.35 ± 0.07, n=8). In contrast to the complete Fstl1 knockout mice, Fstl1 ECKO mice showed lethality starting approximately from the postnatal day 10 (P10). Detailed analysis of the survival rate revealed that about 70% of Fstl1 ECKO mice died by the age of 3-week-old and there was no significant difference between male and female mutants (Supplemental Fig. 1A ).
Further analysis revealed that the hearts of Fstl1 ECKO mice became enlarged ( Fig. 1D ), as also demonstrated by the histological analysis at both P14 and P21 ( Fig. 1E ) and the functional analysis at P10 and P15-17 by the ultrasound imaging system (VisualSonics Vevo 2100, Fig. 1F-H ). There was a significant increase of heart to body weight (HBW) ratio in Fstl1 ECKO mice compared with littermate controls (Fstl1 Flox/+ : 0.79 ± 0.13 %, n=10; Fstl1 Flox/-: 0.78 ± 0.06 %, n=8; Fstl1 ECKO : 1.48 ± 0.55 %, n=7;
Fstl1 ECKO vs Fstl1 Flox/+ :: P=0.0014). The pulmonary vascular resistance (PVR) was calculated by TRV (tricuspid regurgitant velocity) / TVI RVOT (right ventricular outfow time-velocity integral). There was a significant increase of PVR in Fstl1 ECKO mice at P15 ( Fig. 1G ; Fstl1 Flox/+ : 6.58 ± 2.85, n=9; Fstl1 ECKO : 35.56 ± 34.15, n=7; P=0.0227).
The alteration of vascular resistance was also demonstrated by the observation that most of the mutant mice (7 out of 8 mice) showed tricuspid regurgitation at P15 ( Fig.   1F ), while there was only 1 out of 12 Fstl1 ECKO mice detected at P10 ( Fig. 1H ).
However, only 1 out of 5 Fstl1 ECKO mice showed the mitral regurgitation while 5 out of 5 displayed the tricuspid regurgitation. Consistently, there was a significant increase of the right ventricle internal diameter (diastole, Supplemental Figure 1B ; Fstl1 Flox/+ : 0.91 ± 0.35, n=9; Fstl1 ECKO : 1.35 ± 0.39, n=9; P=0.0244) and also the right ventricular cavity area (diastole, Supplemental Figure 1C ; Fstl1 Flox/+ : 3.43 ± 0.73,n=9; Fstl1 ECKO : 5.92 ± 2.14, n=9; P=0.0044). There may be a trend of increase but no significant difference was detected with the left ventricule internal diameter (Fstl1 Flox/+ : 2.92 ± 0.17, n=9; Fstl1 ECKO : 3.20 ± 0.48, n=9; P=0.1159) and the left ventricular cavity area (Fstl1 Flox/+ : 6.15 ± 0.47, n=9; Fstl1 ECKO : 7.69 ± 2.52, n=9; P=0.0894).
Increase of αSMA associated with atrial endocardia and valves of Fstl1 ECKO mice
To investigate causes of the lethality with Fstl1 ECKO mice, we examined heart by immunostaining for αSMA and PECAM-1. There was a dramatic increase of endocardium-associated αSMA + cells in right and left atria ( Fig. 2A, B) . Microvessels in the heart walls of Fstl1 mutant mice also showed an increase of αSMA staining, which is rarely detected in those of control mice ( Fig. 2A, B ). Consistently, a similar change of the αSMA staining, associated with the endothelial cells of valve leaflets, was also detected in the tricuspid and mitral valves ( Fig. 2C , D). However, there was no αSMA staining associated with endocardium of right and left ventricles, and there was also no obvious change of αSMA + microvessels detected in the ventricular walls (Supplemental Fig. 2 ).
To further investigate the effect of non-EC-derived FSTL1 in vascular development, we generated the doubly transgenic mice with Fstl1 deletion in smooth muscle cells (Fstl1 Flox/-;αSMA-Cre, named Fstl1 SMCKO ) or in hematopoietic cells (Fstl1 Flox/-;Vav-iCre, named Fstl1 HCKO ). FSTL1 deletion in Fstl1 SMCKO mice was examined by Western blot analysis (Supplemental Fig. 3A) , and quantitative RT-PCR (Fstl1 Flox/+ : 1.0 ± 0.17, n=5;
Fstl1 Flox/-: 0.46 ± 0.18, n=6; Fstl1 SMCKO : 0.30 ± 0.07, n=7). Deletion of Fstl1 gene in hematopoietic cells of Fstl1 HCKO mice was confirmed by the PCR genotyping of blood cells from mutant or control mice (Supplemental Fig. 3B ). All the Fstl1 SMCKO and Fstl1 HCKO mutant mice survived well by the age of 3-week-old. Surprisingly, although 9 SMCs are one of the major sources of FSTL1 and the SMA-Cre mediated deletion efficiency of FSTL1 is similar to that of Fstl1 ECKO mice at the stage. There were no obvious defects observed in mutant hearts (Supplemental Fig. 3C ) or in the smooth muscle cell coverage with blood vessels of Fstl1 SMCKO mice (Supplemental Fig. 3E ).
Also, there were no detectable heart and vascular abnormalities in Fstl1 Flox/-;Vav-iCre mice (Supplemental Fig. 3D and F).
Excessive αSMA association with lung veins and microvessels in FSTL1 mutant mice
Consistent with the observation in the atria, there was an obvious increase of αSMA staining with blood vessels of lung in Fstl1 ECKO mice (Fig. 3A) . The alteration of αSMA expression was further validated by Western blot analysis in lung (Fig. 3B ). The ratio of αSMA to β-actin was quantified and normalized against the control group ( Fig. 3C ).
There was a significant increase of αSMA in Fstl1 ECKO mice compared with that of the littermate controls ( Fig. 3C ; Fstl1 Flox/+ : 1.0 ± 0.11, n=7; Fstl1 Flox/-: 0.95 ± 0.22, n=6;
Fstl1 ECKO : 1.32 ± 0.24, n=9; Fstl1 ECKO vs Fstl1 Flox/+ : P=0.0060). Interestingly, endomucin, a membrane-bound glycoprotein expressed luminally by venous and capillary ECs, but not by arterial endothelium, was significantly decreased in lungs of the mutant mice ( Fig. 3C ; Fstl1 Flox/+ : 1.0 ± 0.05, n=7; Fstl1 Flox/-: 0.95 ± 0.12, n=6;
Fstl1 ECKO : 0.70 ± 0.19, n=9; Fstl1 ECKO vs Fstl1 Flox/+ : P=0.0010). The decrease of endomucin level could also reflect the alteration of blood pressure (Zahr, Alcaide et al. 2016 ). Interestingly, we found that the increased αSMA was mainly associated with veins and vein-associated microvessels, which were positive for the venous and capillary endothelial cell marker endomucin (Fig. 3A, arrows; lung) . This was further validated by the immunostaining for Dll4, an arterial endothelial cell marker. The blood vessels with abnormal αSMA coating were negative for Dll4 ( Fig. 3D, arrowheads; lung).
Occurrence of blood vessel-associated fibrosis in livers of FSTL1 mutant mice
We further analyzed the vascular associated αSMA in several other tissues including liver, kidney, retina and skin. The increase of αSMA staining was detected by immunostaining in liver (Fig. 4A ), and this was confirmed by Western blot analysis 5C ). This suggests that there may be a differential requirement of endothelial FSTL1 in the regulation of organ-specific vascular systems.
Consistent with the increase of blood vessel-associated αSMA, we also detected the increase of collagen deposition by Sirius red staining in liver of Fstl1 ECKO mice (Fig.   4E ). This was confirmed by the quantification of hydroxyproline content in liver tissue lysates ( Fig. 4F ). There was a significant increase of hydroxyproline in Fstl1 mutant mice compared with the littermate control (Fstl1 Flox/+ : 0.22 ± 0.03 μg / mg, n=6;
Fstl1 ECKO : 0.39 ± 0.16 μg / mg, n=9; P=0.0253).
SMAD3 activation in vein walls of Fstl1 ECKO mutant mice
To check whether there is any transition of endothelial cells into αSMA + cells in blood vessels, we introduced ROSA mT/mG allele into the Fstl1 Flox/-;Tek-cre line and the Fstl1 Flox/+ ;Tek-cre;mT/mG mice was used as control. Interestingly, we found that the αSMA staining was detected mainly at the outer layer of vessel walls in both large and microvessels in the liver of Fstl1 Flox/-;Tek-cre;mT/mG mutant mice (Fig. 5A ). This suggests that the upregulation of αSMA occurred in peri-vascular mural cells.
Consistent with the observations in lung, we found that the increased αSMA was associated with veins and microvessels, which were positive for the venous endothelial cell marker EphB4 (Fig. 5B, arrows ; arrowheads point to arteries).
To examine the alteration of TGFβ mediated signaling, we analyzed the phosphorylation of SMAD3 by the immunostaining (Fig. 6A, B )and western blot analysis (Fig. 6C, D) . The number of pSMAD3 + /αSMA + doubly positive cells associated with blood vessels was significantly increased in livers of Fstl1 ECKO mice compared with that of littermate controls ( Fig. 6A and B ; Fstl1 Flox/+ : 1.3 ± 0.2 / grid, n=4;
Fstl1 ECKO : 7.3 ± 1.1 / grid, n=4; P=0.0001). This was further confirmed by Western blot analysis and the quantification of pSMAD3 : tSMAD2/3 in liver (the ratio normalized against the control as shown in Fig. 6C and D; Fstl1 Flox/+ : 1.0 ± 0.14, n=6; Fstl1 ECKO :
1.83 ± 0.46, n=7; P=0.0014). There was also a slight increase detected with the ratio of pSMAD1/5/8 : tSMAD1 ( Fig. 6D ; Fstl1 Flox/+ : 1.0 ± 0.06, n=6; Fstl1 ECKO : 1.14 ± 0.14, n=6; P=0.0425). A similar increase of SMAD3 activation was also shown in lung (pSMAD3 /tSMAD2/3: Fstl1 Flox/+ : 1.0 ± 0.23, n=6; Fstl1 ECKO : 1.44 ± 0.26, n=7; P=0.0086), while there was no significant difference observed with pSMAD1/5/8: tSMAD1 (Fstl1 Flox/+ : 1.0 ± 0.31, n=6; Fstl1 ECKO : 1.08 ± 0.40, n=6; P=0.7047).
Discussion
We have shown in this study that the EC-derived FSTL1 is required for the homeostasis of cardiovascular system. Lack of endothelial FSTL1 led to a dramatic increase of αSMA association with veins and associated microvessels, in addition to the abnormal remodeling with atrial endocardia as well as heart valves. At the molecular level, an enhanced activation of SMAD3 signaling was detected in vascular mural cells in the absence of endothelial FSTL1, while the SMAD1/5/8 pathway was 13 only mildly affected. The excessive αSMA would promote the cardiac rigidity and decrease the vascular elasticity. This may directly account for the alteration of vascular resistance as reflected by the occurrence of tricuspid regurgitation and the heart failure of the EC-specific Fstl1 mutant mice.
It was previously reported that deletion of FSTL1 led to the abnormal development of mitral valves (Prakash, Borreguero et al. 2017) . It is worth noting that the authors used a different Tie2-Cre deletor from the line used in our study (Koni, Joshi et al. 2001 ). With the Tie2-Cre transgenic mice used by Prakash et al. (Prakash, Borreguero et al. 2017) , the Cre recombinase-mediated gene recombination occurred not only in endothelial cells, but also in mesenchymal cells of atrioventricular canal and the proximal cardiac outflow tract (Kisanuki, Hammer et al. 2001) . It is likely that the defects with mitral valves observed by Prakash et al. was at least partly due to the loss of FSTL1 in mesenchymal cells (Prakash, Borreguero et al. 2017) . In this study, we found that the tricuspid valves displayed a more severe abnormality with the regurgitation detected earlier than that of mitral valves. We speculate that the lethality of Fstl1 ECKO mice in our study may result from the abnormal remodeling of cardiovascular system in a systemic level. Firstly, the excessive αSMA + cell investment with vessel walls detected in several organs would increase the peripheral vascular resistance. Secondly, the increased association of αSMA with atrial endocardia and heart valves would increase the cardiac rigidity. Both factors would ultimately contribute to the hypertension and heart failure of Fstl1 ECKO mutant mice. Pathogenesis of pulmonary hypertension often involves the abnormal vascular muscularization affecting mainly arterioles, such as the increased proliferation of vascular SMCs (Voelkel, Natarajan et al. 2011 , Tuder, Archer et al. 2013 . It has been shown that TGFβ mediated signaling is implicated in the development of pulmonary hypertension, with genetic mutations identified in several genes of this pathway including ALK1, BMPR2, endoglin, BMP9 and the downstream mediators (Goumans, Liu et al. 2009 , Machado, Southgate et al. 2015 , Wang, Fan et al. 2016 . BMPR2 haploinsufficiency was shown to cause pulmonary arterial hypertension (PAH) (Machado, Pauciulo et al. 2001) , while overexpression of BMPR2 in endothelial cells ameliorated PAH via the suppression of Smad2/3 signaling (Harper, Reynolds et al. 2016 ). Furthermore, targeted disruption of SMAD3 signaling suppressed the pathological processes of vascular or interstitial fibrosis in several other organs examined (Sato, Muragaki et al. 2003 , Wang, Huang et al. 2006 , Lee, Wright et al. 2016 , Liu, Das et al. 2017 . FSTL1 is a TGFβ inducible factor (Shibanuma, Mashimo et al. 1993) . We found in this study that the endothelial FSTL1 deficiency led to a significant increase of SMAD3 activation but only a mild change with SMAD1/5/8 phosphorylation, suggesting a negative effect of FSTL1 on TGFβ pathway.
Consistently, we observed that there was an upregulation of αSMA expression in the cardiovascular system, accounting for the occurrence of hypertension in Fstl1 ECKO mutants. The alteration of vascular resistance in Fstl1 ECKO mice was also reflected by the decrease of luminally expressed endomucin in venous and capillary endothelia, 15 as fluid shear stress was shown to downregulate its surface localization (Zahr, Alcaide et al. 2016) . Surprisingly, we found in this study that the increase of αSMA mainly occurred with atria and vein-associated vessels, which was accompanied by the increased collagen deposition as demonstrated in liver, a typical feature of tissue fibrosis. It is possible that EC-derived FSTL1 may maintain the quiescence of peri-endothelium / -endocardium mural cells or mesenchymal cells by antagonizing TGFβ signaling. It remains to be investigated about the mechanism underlying the discrepancy between veins versus arteries in response to the loss of endothelial FSTL1. In addition, it is unclear why the abnormal vascular remodeling occurred postnatally with Fstl1 ECKO mice, but without any obvious abnormalities observed during embryogenesis even in Fstl1 conventional knockout mice (our unpublished observation).
In addition, FSTL1 is expressed also by vascular mural cells and the muscle-derived FSTL1 was shown to have beneficial effects on cardiovascular functions or tissue repair in pathological conditions such as pressure overload or injury (Shimano, Ouchi et al. 2011 , Miyabe, Ohashi et al. 2014 ). However, we found that deletion of FSTL1 in SMCs did not affect blood vascular formation and remodeling in development. This is consistent with the recent finding that FSTL1 from different cell-types (e.g. myocardial versus epicardial cells) exerts distinct functions in heart, which may be due to the differential protein glycosylation (Wei, Serpooshan et al. 2015) . Furthermore, the significant increase of αSMA was detected in atria, liver, lung and kidney of Fstl1 ECKO mice, but not obvious with skin and retinal blood vessels examined. This implies a potential role of tissue microenvironment on the biological functions of FSTL1.
To summarize, the requirement of EC-derived FSTL1 for vascular homeostasis adds a new factor to the regulatory network for vascular health. It is still to be investigated about the differential effects of EC-versus SMC-derived FSTL1 on vascular maintenance and the distinct requirement of endothelial FSTL1 in different organs.
Furthermore, this study also introduced a genetically modified disease model for the investigation of mechanisms underlying pathological heart remodeling related to pulmonary or systemic hypertension.
Methods
Animal work
All animal experiments were performed in accordance with the institutional guidelines of Soochow University Animal Center. Conditional knockout mice targeting Fstl1 gene (Fstl1 Flox ) were generated as previously described (Li, Zhang et al. 2011) . Fstl1 ＋/mice were obtained by crossing of Fstl1 Flox mice with EIIA-Cre mice (Lakso, Pichel et al. 1996) . Tek-Cre mice were used to generate the endothelial cell specific knockout mouse models (Fstl1 Flox/-;Tek-Cre, named Fstl1 ECKO ) (Koni, Joshi et al. 2001 
Echocardiography
Echocardiography of FSTL1 mutant and control mice (P10 -P17) was performed using a Vevo 2100 ultrasound system (VisualSonics). Mice were anesthetized with isoflurane at 3 % for induction and at 1-1.5 % for maintenance. Skin hairs of chest regions were removed. For the analysis of heart function, peak tricuspid regurgitation velocity (TRV) was measured using pulsed-wave Doppler and the highest velocity recorded from multiple views was used，including apical 4-chamber, parasternal and subcostal views.
Immunostaining
For whole mount immunostaining, ears were harvested, fixed in 4 % paraformaldehyde, blocked with 3 % (w/v) milk in PBS-TX (0.3 % Triton X-100), and incubated with primary antibodies overnight at 4 C. For the frozen tissue section staining, tissues were collected and fixed in 4 % PFA for 2 h at 4℃,followed by the incubation in 20% sucrose overnight before being embedded in OCT. Frozen sections of 10 µm were used. The antibodies used were rat anti-mouse PECAM-1 (BD Pharmigen, 553370), Cy3-αSMA (Sigma C6198), Endomucin (eBioscience, 14-5851), pSMAD3 (abcam ab52903) and FSTL1 (R&D, AF1738). Appropriate Alexa 488, Alexa594 (Invitrogen) conjugated secondary antibodies were used. All fluorescently labeled samples were mounted and analyzed with a confocal microscope (Olympus Flueview 1000), or Leica MZ16F fluorescent dissection microscope.
Quantitative real-time RT-PCR
Lung tissues from Fstl1 mutant and control mice were collected and homogenized in Trizol (Ambion). RNA extraction and reverse transcription was performed following standard procedures (RevertAid First Strand cDNA Synthesis Kit, Thermo Scientific).
Quantitative real-time RT-PCR was carried out using the SYBR premix Ex Taq kit (TaKaRa). Briefly, for each reaction, 50 ng of total RNA was transcribed for 2 min at 50 ℃ and a denaturing step at 95 ℃ for 30 s, then followed by 40 cycles of 5 s at 95 ℃ and 34 s at 60 ℃. Fluorescence data were collected and analyzed using ABI PRISM 7500. The primers used were as follows: FSTL1:
5'-TCTGTGCCAATGTGTTTTGTGG-3', 5'-TGAGGTAGGTCTTGCCATTACTG-3';
GAPDH: 5'-GGTGAAGGTCGGTGTGAACG-3', 5'-CTCGCTCCTGGAAGATGGTG-3'.
Sirius red staining and hydroxyproline quantification
Collagen deposition in tissues were analyzed by sirius red staining and the quantification of hydroxyproline. Briefly, tissues were collected and fixed in 4% paraformaldehyde overnight at 4°C. Paraffin sections (6 μm) were processed for staining first with hematoxylin, followed by the Picro-sirius red (Sigma-Aldrich) staining for one hour (0.5 g Direct Red 80 dissolved in 500 ml 1.3% Picric acid from Sangon, Shanghai). Sections were then washed, dehydrated and mounted in the mounting medium for further microscopic analysis. For the measurement of tissue collagen content by the hydroxyproline quantification, liver tissues (60 mg) were subjected to the alkaline hydrolysis and hydroxyproline concentration in the tissue lysate was determined following the manufacturer's instructions (Jiancheng, Nanjing, China) as follows: (Sample OD valueblank OD) / (standard OD-blank OD) × standard sample concentration (5 μg / ml) × total hydrolysate volume (10 ml) / tissue wet weight (mg).
Western blot
For the analysis of FSTL1 expression and deletion efficiency, tissues were washed with ice cold PBS and lysed in lysis buffer (1 mM PMSF, 2 mM Na 3 VO 4 , 1× protease and phosphatase inhibitor cocktail tablets without EDTA from Roche Applied Science, 20 20 mM Tris-HCl pH 8.0, 100 mM NaCl, 10 % Glycerol, 50 mM NaF, 10 mM β-glycerolphosphate, 5 mM Sodium pyrophosphate, 5 mM EDTA, 0.5 mM EGTA, 1 % NP-40). The lysates were incubated on ice for 0.5 hour with rotation and was clarified by centrifugation. Protein concentration was determined using the BCA protein assay kit (PIERCE). Equal amounts of protein were used for analysis. Antibodies used include goat anti-mouse FSTL1 (R&D, BAF1738), mouse anti-all αSMA (sigma A2547), pSMAD3 (abcam ab52903), tSMAD2/3 (R&D3797), pSMAD1/5/8 (cell signaling 9511S), tSMAD1 (cell signaling 9743S), and mouse monoclonal to β-actin antibody (C4, Santa Cruz sc-47778).
Statistics
Statistical analysis was performed with the unpaired t test. All statistical tests were two-sided. 
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